Scortis Pharma Limited - Company Profile

It is a pharma public limited company based in C, Rajasthan, India, established in 1998.
1998 C, Rajasthan, India Active
Last Updated:
Access Report
About Scortis Pharma Limited

Scortis Pharma Limited, a active public limited company, was established on 23 March 1998 in C, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232RJ1998PLC014717. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

It upholds a compliant status. Its leadership includes Aniruddh Modi (Director), Anjali Modi (Director), Ashish Modi (Director). Past directors included Vishwambhar Modi, Daya Nandan Modi, Gautam Nathany. It holds no open charges and ₹3.20 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 48, Shivaji Nagar,Civil Lines,Jaipur. Jaipur., C, Rajasthan.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232RJ1998PLC014717

  • Registration Number

    014717

  • Incorporation Date

    23 March 1998

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 27 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 3.20 M
  • Revenue Growth **** -3.25%
  • Profit Growth **** 167.50%
  • Ebitda **** -7.79%
  • Net Worth 22.32%
  • Total Assets **** 1.62%
Company report

Scortis Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Scortis Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Scortis Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Aniruddh Modi Director 06 Jul 2019 Current
Anjali Modi Director 30 May 2000 Current
Ashish Modi Director 30 Mar 1998 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jul 2019 Past
Pramod Abcsdd Director 06 Jul 2019 Past
Pramod Abcsdd Director 21 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scortis Pharma.

Scortis Pharma Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.25% decrease. The company also saw a substantial improvement in profitability, with a 167.5% increase in profit. The company's net worth Soared by an impressive increase of 22.32%.

Scortis Pharma revenue growth over time
Scortis Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -3.25%
*******
*******
*******
*******
Revenue from Operations
*******
 -3.43%
*******
*******
*******
*******
Total Assets
*******
 1.62%
*******
*******
*******
*******
Profit or Loss
*******
 167.50%
*******
*******
*******
*******
Net Worth
*******
 22.32%
*******
*******
*******
*******
EBITDA
*******
 -7.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scortis Pharma?

In 2019, Scortis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹3,200,000.00

Charges Breakdown by Lending Institutions
  • Kotak Mahindra Prime Limited : 0.17 Cr
  • Bank Of Baroda : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
12 Feb 2016 Kotak Mahindra Prime Limited ₹1.70 M Satisfied
23 May 2005 Bank Of Baroda ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Scortis Pharma?

Unlock and access historical data on people associated with Scortis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scortis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scortis Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scortis Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Scortis Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Scortis Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was recorded as a recent event.

  • Charges

    The activity A charge registered on 12 Feb 2016 via Charge ID 10623736 with Kotak Mahindra Prime Limited was fully satisfied on 09 Sep 2024. was completed.

  • Charges

    Progress on A charge registered on 23 May 2005 via Charge ID 90071496 with Bank Of Baroda was fully satisfied on 23 Aug 2024. was documented.

  • Director Appointment

    The activity Aniruddh Modi was appointed as a Director was appointed as a Director on 06 Jul 2019 & has been associated with this company since 6 years 7 months . was completed.

  • Charges

    A charge with Kotak Mahindra Prime Limited amounted to Rs. 1.70 M with Charge ID 10623736 was registered on 12 Feb 2016. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scortis Pharma Limited?

The CIN of Scortis Pharma Limited is U24232RJ1998PLC014717.

Where is Scortis Pharma Limited headquartered?

Scortis Pharma Limited is headquartered at 48, Shivaji Nagar,Civil Lines,Jaipur. Jaipur., C, Rajasthan.

When was Scortis Pharma Limited incorporated?

Scortis Pharma Limited was incorporated on 23 March 1998.

Who are the current directors of Scortis Pharma Limited?

The current directors of Scortis Pharma Limited are

What is the primary industry of Scortis Pharma Limited?

The primary industry of Scortis Pharma Limited is Manufacturing.

Is Scortis Pharma Limited a listed company?

Scortis Pharma Limited is unlisted.

What is the capital structure of Scortis Pharma Limited?

The authorized capital of Scortis Pharma Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

What is the compliance status of Scortis Pharma Limited?

The compliance status of Scortis Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available